# Temporal control of CAR expression by a tumor-targeting albumin adapter and logic gating enhances CAR-T cell therapy for solid tumors

Source: [cell.com](https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00582-3?rss=yes) · 2026-11-11 · Medicine
Page: https://themorning.science/story/temporal-control-of-car-expression-by-a-tumor-targeting-albumin-adapter-and-logi-69d1cbcb851430fc
Kind: research · Impact: medium

## In brief

- Chen et al. describe MANAGE CAR-T cells that use an artificial-antigen-sensing synNotch receptor to gate CAR expression.
- An albumin-based tumor-targeting adapter carrying the artificial antigen is used to prime the CAR-T cells.
- Adjusting the adapter dosing schedule is reported to enable tumor-restricted CAR-T activity in solid tumors.

## Why it matters

It describes a logic-gated, time-controlled CAR-T approach aimed at making cell therapy more targeted against solid tumors, a known hurdle for CAR-T treatment.

## Timeline

- 2026-11-11: Study published in Cell Reports Medicine

## Coverage

- [Temporal control of CAR expression by a tumor-targeting albumin adapter and logic gating enhances CAR-T cell therapy for solid tumors](https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00582-3?rss=yes) — cell.com, 2026-11-11

Tags: car-t, cell therapy, solid tumors, synthetic biology, immunotherapy

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science